Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 477

Similar articles for PubMed (Select 22691694)

1.

Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.

Cavanaugh JS, Kazennyy BY, Nguyen ML, Kiryanova EV, Vitek E, Khorosheva TM, Nemtsova E, Cegielski JP.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1069-74. doi: 10.5588/ijtld.11.0696. Epub 2012 Jun 11.

PMID:
22691694
2.

Predictors and mortality associated with treatment default in pulmonary tuberculosis.

Kliiman K, Altraja A.

Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

PMID:
20202304
3.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
4.

Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.

Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1228-33. doi: 10.5588/ijtld.12.0037. Epub 2012 Jun 28.

PMID:
22748131
5.

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522. Epub 2012 Feb 29.

PMID:
22390880
6.

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.

Ann Intern Med. 2006 May 2;144(9):650-9.

PMID:
16670134
7.

Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.

Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1331-3. doi: 10.5588/ijtld.11.0098.

PMID:
22283890
8.

Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.

Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.

Int J Tuberc Lung Dis. 2014 May;18(5):564-70. doi: 10.5588/ijtld.13.0602.

PMID:
24903794
9.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

10.

Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.

Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, Lee J.

Chest. 2000 Mar;117(3):744-51.

PMID:
10713001
11.

Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB.

Kliiman K, Altraja A.

Eur Respir J. 2009 May;33(5):1085-94. doi: 10.1183/09031936.00155708. Epub 2009 Jan 22.

12.

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.

Shin SS, Keshavjee S, Gelmanova IY, Atwood S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Barnashov A, Tonkel TP, Cohen T.

Am J Respir Crit Care Med. 2010 Aug 1;182(3):426-32. doi: 10.1164/rccm.200911-1768OC. Epub 2010 Apr 22.

13.

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.

Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.

Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.

14.

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ, Lee CH, Shim TS.

Am J Respir Crit Care Med. 2010 Jul 1;182(1):113-9. doi: 10.1164/rccm.200911-1656OC. Epub 2010 Mar 11.

PMID:
20224066
15.

Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.

Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, Woo PC.

PLoS One. 2011 Apr 29;6(4):e19399. doi: 10.1371/journal.pone.0019399.

16.

Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.

Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43. doi: 10.5588/ijtld.11.0811.

PMID:
23107633
17.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

18.

Diagnostic sensitivity of culture and drug resistance patterns in Korean patients with intestinal tuberculosis.

Ye BD, Yang SK, Kim D, Shim TS, Kim SH, Kim MN, Lee YJ, Na HK, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Kim JH.

Int J Tuberc Lung Dis. 2012 Jun;16(6):799-804. doi: 10.5588/ijtld.11.0252. Epub 2012 Apr 9.

PMID:
22508109
19.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

20.

Clinical evolution of a group of patients with multidrug-resistant TB treated at a referral center in the city of Rio de Janeiro, Brazil.

Siqueira HR, Freitas FA, Oliveira DN, Barreto AM, Dalcolmo MP, Albano RM.

J Bras Pneumol. 2009 Jan;35(1):54-62. English, Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk